U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Celebrity Inventors

Magician Harry Houdini patented a "Diver's Suit" enabling the wearer to "quickly divest himself of the suit while being submerged and to safely escape and reach the surface of the water."

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Attorney: Berstein; David L.


Number of patents: 28
Last date: February 14, 2012

NumberTitleIssue Date
8114874Substituted acetylenic imidazo[1,2-B]pyridazine compounds as kinase inhibitors
This invention relates to compounds of the general formula: in which the variable groups are as defined herein, and to their preparation and use. In particular, the compounds include embodiments in ...
02/14/2012
8106191Synthetic multimerizing agents
New compounds are disclosed for multimerizing immunophilins and proteins containing immunophilin or immunophilin-related domains. The compounds are of the formula M-L-Q where M is a synthetic ligand for an FKBP protein. ...
01/31/2012
8058426Phosphorus-containing compounds and uses thereof
This invention concerns a new family of phosphorus-containing compounds containing a moiety JQA- in which: A is absent or is —O—, —S— or —NR2—; Q is absent or (if A is —O—, —S— or —NR2—) Q may be —V—, â...
11/15/2011
7709020Implantable device comprising phosphorus-containing macrolides
This invention concerns a new family of phosphorus-containing compounds containing a moiety JQA- in which: A is absent or is —O—, —S— or —NR2—; Q is absent or (if A is —O—, —S— or —NR2—) Q may be —V—, â...
05/04/2010
7432277Phosphorus-containing macrocycles
This invention concerns a new family of phosphorus-containing macrocycles containing various phosphonate- and phosphonate-containing moieties. ...
10/07/2008
7238679Heterocycles and uses thereof
Compounds of the following formula are disclosed: wherein RB is a substituted or unsubstituted aryl or heteroaryl moiety; at least one of RU and RL is a phosphorus-containing moie...
07/03/2007
7186826Phosphorus-containing compounds and uses thereof
This invention concerns a new family of phosphorus-containing compounds containing a moiety JQA— in which: A is absent or is —O—, —S— or —NR2—; Q is absent or (if A is —O—, —S— or —NR2—) Q may...
03/06/2007
7115589Purine derivatives
This invention relates to compounds of the general formula: in which RA, RB, RC and RD are as defined herein, and to their preparation and use. In these compounds, R
10/03/2006
7091213Phosphorus-containing compounds and uses thereof
This invention concerns a new family of phosphorus-containing compounds containing a moiety JQA- in which: A is absent or is —O—, —S— or —NR2—; Q is absent or (if A is —O—, —S— or —NR2—) Q may b...
08/15/2006
7019139Quinolinones and uses thereof
The invention relates to compounds of the general formula (and pharmaceutically acceptable derivatives thereof): in which RA, RB, RC, RD, R5, R7, R9...
03/28/2006
7009054Quinolines and uses thereof
This invention relates to compounds of the general formula: in which RA, RB, RC and RD are as defined herein, and to their preparation and use. ...
03/07/2006
6693189Materials and method for treating or preventing pathogenic fungal infection
This invention concerns derivatives of rapamycin and their antifungal uses. Also disclosed are materials and methods relevant to the identification of non-immunosuppressive anti-fungal rapamycin derivatives. Use of compounds, among others, of the formula ...
02/17/2004
6649595Regulation of biological events using novel compounds
Materials and methods are disclosed for regulation of biological events such as target gene transcription and growth, proliferation or differentiation of engineered cells....
11/18/2003
6576766Signal transduction inhibitors, compositions containing them
This invention concerns compounds for inhibiting intracellular signal transduction, especially intracellular signal transduction mediate by one or more molecular interactions involving a phosphotyrosine-containing protein. This invention also relates to p...
06/10/2003
6573295Bicyclic signal transduction inhibitors, compositions containing them & uses thereof
This invention concerns compounds for inhibiting intracellular signal transduction, especially intracellular signal transduction mediated by one or more molecular interactions involving a phosphotyrosine-containing protein. This invention also relates to ...
06/03/2003
6566073Materials and methods involving conditional retention domains
Materials and methods involving conditional retention domains (CRDs) are disclosed. Also disclosed are fusion proteins containing CRDs and cells expressing such fusion proteins. In addition, the invention provides novel methods for producing target protei...
05/20/2003
6506379Intramuscular delivery of recombinant AAV
This invention concerns new configurations for biological switches and provides new methods and materials useful for regulating biological events in animal cells. The invention involves recombinant DNA constructs comprising DNA sequences derived from sequ...
01/14/2003
6482852Bicyclic signal transduction inhibitors, compositions containing them & uses thereof
This invention concerns compounds for inhibiting intracellular signal transduction, especially intracellular signal transduction mediated by one or more molecular interactions involving a phosphotyrosine-containing protein. This invention also relates to ...
11/19/2002
6479653Compositions and method for regulation of transcription
The present invention relates to novel fusion proteins which activate transcription, to nucleic acid constructs encoding the proteins and their use in the genetic engineering of cells....
11/12/2002
6306649Heterologous transcription factors
This invention provides novel materials and methods involving the heterologous expression of transcription factors which are useful for effecting transcription of target genes in genetically engineered cells or organisms containing them. Target gene const...
10/23/2001
6303319Cell based assay for identifying sh2-domain-specific signal transducer antagonist
The present invention provides methods and compositions for identifying inhibitors of the interaction between phosphopeptide binding pairs, i.e., a protein domain having at least one phosphopeptide binding domain and the phosphorylated ligands that bind t...
10/16/2001
6258823Materials and method for treating or preventing pathogenic fungal infection
This invention concerns derivatives of rapamycin and their antifungal uses. Also disclosed are materials and methods relevant to the identification of non-immunosuppressive antifungal rapamycin derivatives....
07/10/2001
6207397In vitro fluorescence polarization assay
An in vitro assay method permits the identification of a test substance which inhibits the mutual association of two molecules. The method includes the steps of providing two components capable of mutual association, one of said components bearing a coval...
03/27/2001
6187757Regulation of biological events using novel compounds
Materials and methods are disclosed for regulation of biological events such as target gene transcription and growth, proliferation or differentiation of engineered cells....
02/13/2001
5939528Crystalline FRAP complex
The invention relates to the human protein FRAP, and in particular to the FKBP12-rapamycin binding domain thereof and to the ternary complex formed by the FRB domain, rapamycin and FKBP12. A new crystalline composition comprising the ternary complex, coor...
08/17/1999
5710129Inhibitors of SH2-mediated processes
This invention relates to compounds of formula: ##STR1## and pharmaceutically acceptable salts thereof, where A is H, R1, --CO--R1 or --CO--OR1 where R1 is a substituted or unsubstituted alkyl, heteroalkyl,...
01/20/1998
4835260Erythropoietin composition
A new improved glycoprotein having erythropoietin-type activity is disclosed. The substrate is characterized by amino acid sequence substantially identical to the amino acid sequence of native human erythropoietin wherein the methionine-54 is replaced wit...
05/30/1989
4677195Method for the purification of erythropoietin and erythropoietin compositions
A method for purifying erythropoietin is described. The method comprises treating partially purifying erythropoietin by reverse phase high performance liquid chromatography to obtain homogeneous erythropoietin having a molecular weight of about 34,000 dal...
06/30/1987
 
Sign InRegister
Username  
Password   
forgot password?